Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	23,215	10,576	25,891	16,074	8,451	2,820
Market Cap Growth	106.97%	-59.15%	61.07%	90.20%	199.72%	-18.91%
Enterprise Value	20,418	8,085	23,747	15,869	8,249	2,326
Last Close Price	148.00	73.55	178.94	118.56	65.84	23.11
PE Ratio	34.96	22.37	35.62	-	-	-
PS Ratio	17.36	12.73	23.40	81.32	289.08	97.71
PB Ratio	5.50	3.39	9.39	22.29	18.25	5.23
P/TBV Ratio	6.75	4.89	9.52	23.46	19.80	5.59
P/FCF Ratio	98.09	21.59	38.79	-	-	-
P/OCF Ratio	92.03	21.25	38.74	-	-	-
EV/Sales Ratio	15.26	9.73	21.47	80.28	282.15	80.61
EV/EBITDA Ratio	26.11	19.20	34.00	-	-	-
EV/EBIT Ratio	26.57	19.34	34.25	-	-	-
EV/FCF Ratio	86.27	16.51	35.58	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.04	0.03	0.03
Debt / EBITDA Ratio	0.06	0.09	0.02	-	-	-
Debt / FCF Ratio	0.21	0.08	0.02	-	-	-
Asset Turnover	0.34	0.26	0.58	0.31	0.05	0.04
Quick Ratio	9.13	8.49	12.89	11.63	10.05	9.05
Current Ratio	9.17	8.72	12.96	13.07	10.57	10.79
Return on Equity (ROE)	17.42%	16.10%	41.81%	-6.76%	-49.43%	-41.47%
Return on Assets (ROA)	12.36%	8.07%	22.64%	-8.54%	-29.36%	-27.20%
Return on Capital (ROIC)	13.40%	8.82%	24.62%	-8.99%	-30.89%	-28.46%
Return on Capital Employed (ROCE)	18.00%	13.10%	24.50%	-	-	-
Earnings Yield	2.67%	4.47%	2.81%	-0.25%	-2.93%	-10.00%
FCF Yield	1.02%	4.63%	2.58%	-1.32%	-2.19%	-11.20%
Dividend Yield	1.02%	2.04%	0.56%	-	-	-
Payout Ratio	-	29.84%	-	-	-	-
Buyback Yield / Dilution	-4.72%	-4.73%	-7.29%	-6.65%	-1.87%	-5.35%
Total Shareholder Return	-3.71%	-2.69%	-6.73%	-6.65%	-1.87%	-5.35%

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.